Niftafly 100 Tablet contains Nitrofurantoin SR 100mg, a sustained-release antibacterial agent indicated for the treatment and prophylaxis of urinary tract infections caused by susceptible bacteria. It helps relieve symptoms such as dysuria, urinary frequency, and lower abdominal discomfort.
Nitrofurantoin works by inhibiting bacterial enzymes, disrupting cell wall synthesis and bacterial growth. The sustained-release formulation ensures prolonged therapeutic effect, reducing dosing frequency and improving patient compliance.
For distributors and healthcare suppliers, Niftafly 100 Tablet is a high-demand urinary tract therapy product, widely used in hospitals, clinics, and community pharmacies. The persistent prevalence of UTIs ensures steady demand throughout the year.
Adding Niftafly 100 Tablet to your antibacterial and UTI therapy segment creates strong opportunities in pharmacies, hospitals, urology clinics, export markets, and third-party manufacturing. Its proven efficacy, sustained-release advantage, and prescriber confidence make it a valuable addition to pharmaceutical distribution portfolios.